公开(公告)号：EP2068723A2

公开(公告)日：2009-06-17

申请号：EP07843455.2

申请日：2007-09-28

Applicant: Pluromed, Inc.

Inventor： VOGEL, Jean-marie ,  WILKIE, James, A.

IPC: A61B17/12

CPC classification number: A61B17/12186 ,  A61B17/12022 ,  A61B17/12099 ,  A61B17/12109 ,  A61B17/12195 ,  A61B17/22012 ,  A61B18/26 ,  A61B2017/22067 ,  A61M5/007

Abstract: One aspect of the present invention provides a method for the treatment of lithiasis, which mitigates the risk of damage to surrounding body tissue when removing a calculi (e.g., biological concretions, such as urinary, biliary, and pancreatic stones) that obstructs or may otherwise be present within a body's anatomical lumen. In one embodiment, the instant invention provides a method of using a polymer plug to occlude a lumen distal to a calculi, whereby calculi fragments resulting from lithotripsy are prevented from traveling up the lumen. In certain embodiments, a dual lumen catheter is utilized to inject two solutions proximal to the calculi, the mixing of said solutions causing a polymer plug to form.

公开(公告)号：EP1993651A4

公开(公告)日：2009-06-10

申请号：EP07753286

申请日：2007-03-14

Applicant: KCI LICENSING INC

Inventor： JOHNSON ROYCE W ,  SWAIN LARRY D ,  CORNET DOUGLAS A ,  MANWARING MICHAEL ,  KAGAN JONATHAN

IPC: A61M29/00 ,  A61F2/958

CPC classification number: A61H9/005 ,  A61B17/12168 ,  A61B17/12181 ,  A61B17/12186 ,  A61B17/1219 ,  A61B17/12195 ,  A61B17/1355 ,  A61B17/80 ,  A61B17/88 ,  A61F2/0077 ,  A61F2/30767 ,  A61F2/36 ,  A61F2/3662 ,  A61F13/00068 ,  A61F13/0216 ,  A61F2002/0086 ,  A61F2002/30677 ,  A61F2002/3068 ,  A61F2002/30785 ,  A61F2002/30787 ,  A61F2002/30968 ,  A61F2002/3611 ,  A61F2002/3625 ,  A61F2002/368 ,  A61F2002/3694 ,  A61F2310/00395 ,  A61F2310/00592 ,  A61F2310/00928 ,  A61H2201/0103 ,  A61L31/146 ,  A61M1/0023 ,  A61M1/0037 ,  A61M1/0084 ,  A61M1/0088 ,  A61M1/0092 ,  A61M5/14 ,  A61M27/00 ,  A61M37/00 ,  A61M2025/1086

Abstract: A method of administering a reduced pressure tissue treatment to a tissue site includes percutaneously inserting a tube through a skin tissue of a patient to place a distal end of the tube adjacent the tissue site, the tube having at least one passageway. A balloon associated with the tube is positioned adjacent the tissue site, and the balloon is inflated to dissect and form a void adjacent the tissue site. A manifold having a plurality of flow channels is delivered through the passageway to the tissue site. The manifold is positioned such that at least one of the flow channels is in contact with the tissue site, and a reduced pressure is applied to the tissue site through the flow channels of the manifold.

公开(公告)号：EP1582179A3

公开(公告)日：2009-04-01

申请号：EP05013022.8

申请日：2000-02-01

Applicant: Board of Regents, The University of Texas System

Inventor： Konya, Andras ,  Hyodoh, Hideki ,  Wright, Kenneth C.

IPC: A61F2/06

CPC classification number: A61F2/90 ,  A61B17/12118 ,  A61B17/12186 ,  A61B17/12195 ,  A61B2017/00526 ,  A61B2017/00575 ,  A61B2017/00867 ,  A61B2017/12054 ,  A61F2/01 ,  A61F2/856 ,  A61F2/95 ,  A61F2/954 ,  A61F2002/016 ,  A61F2002/018 ,  A61F2002/9511 ,  A61F2210/0004 ,  A61F2220/0016 ,  A61F2220/0075 ,  A61F2230/0006 ,  A61F2230/001 ,  A61F2230/0015 ,  A61F2230/005 ,  A61F2230/0067 ,  A61F2230/0069 ,  A61F2230/0076 ,  A61F2230/0078 ,  A61F2230/008 ,  A61F2230/0091 ,  A61F2230/0093

Abstract: The present invention relates to a device for delivering an axially and radially expandable woven body having two ends into an anatomical structure, the device comprising:
a first tube configured to accept a guide wire; and
a second tube configured to fit over the first tube;
wherein one end of the axially and radially expandable woven body is secured to the outside of the first tube and the other end of the axially and radially expandable woven body is secured to the outside of the second tube, when the tubes are used for delivering the axially and radially expandable woven body.

公开(公告)号：EP1993652A2

公开(公告)日：2008-11-26

申请号：EP07753287.7

申请日：2007-03-14

Applicant: KCI Licensing, Inc.

Inventor： CORNET, Douglas, A. ,  MANWARING, Michael ,  SWAIN, Larry, D. ,  KAGAN, Jonathan

IPC: A61M29/00

CPC classification number: A61H9/005 ,  A61B17/12168 ,  A61B17/12181 ,  A61B17/12186 ,  A61B17/1219 ,  A61B17/12195 ,  A61B17/1355 ,  A61B17/80 ,  A61B17/88 ,  A61F2/0077 ,  A61F2/30767 ,  A61F2/36 ,  A61F2/3662 ,  A61F13/00068 ,  A61F13/0216 ,  A61F2002/0086 ,  A61F2002/30677 ,  A61F2002/3068 ,  A61F2002/30785 ,  A61F2002/30787 ,  A61F2002/30968 ,  A61F2002/3611 ,  A61F2002/3625 ,  A61F2002/368 ,  A61F2002/3694 ,  A61F2310/00395 ,  A61F2310/00592 ,  A61F2310/00928 ,  A61H2201/0103 ,  A61L31/146 ,  A61M1/0023 ,  A61M1/0037 ,  A61M1/0084 ,  A61M1/0088 ,  A61M1/0092 ,  A61M5/14 ,  A61M27/00 ,  A61M37/00 ,  A61M2025/1086

Abstract: A reduced pressure delivery system is provided and includes a primary manifold, a blockage prevention member, and first and second conduits in fluid communication with the primary manifold. The primary manifold includes a flexible wall surrounding a primary flow passage and is adapted to be placed in proximity to a tissue site. The blockage prevention member is positioned within the primary flow passage. A plurality of apertures is disposed in the flexible wall to communicate with the primary flow passage. The first conduit is fluidly connected to the primary flow passage to deliver reduced pressure through the primary flow passage and the plurality of apertures. The second conduit includes an outlet proximate the primary flow passage or an outlet of the first conduit to purge the primary flow passage or first conduit to prevent blockages.

公开(公告)号：EP1993491A2

公开(公告)日：2008-11-26

申请号：EP07753289.3

申请日：2007-03-14

Applicant: KCI Licensing, Inc.

Inventor： CORNET, Douglas, A. ,  SWAIN, Larry, D. ,  JOHNSON, Royce, W. ,  MANWARING, Michael ,  KAGAN, Jonathan

IPC: A61F5/00

CPC classification number: A61H9/005 ,  A61B17/12168 ,  A61B17/12181 ,  A61B17/12186 ,  A61B17/1219 ,  A61B17/12195 ,  A61B17/1355 ,  A61B17/80 ,  A61B17/88 ,  A61F2/0077 ,  A61F2/30767 ,  A61F2/36 ,  A61F2/3662 ,  A61F13/00068 ,  A61F13/0216 ,  A61F2002/0086 ,  A61F2002/30677 ,  A61F2002/3068 ,  A61F2002/30785 ,  A61F2002/30787 ,  A61F2002/30968 ,  A61F2002/3611 ,  A61F2002/3625 ,  A61F2002/368 ,  A61F2002/3694 ,  A61F2310/00395 ,  A61F2310/00592 ,  A61F2310/00928 ,  A61H2201/0103 ,  A61L31/146 ,  A61M1/0023 ,  A61M1/0037 ,  A61M1/0084 ,  A61M1/0088 ,  A61M1/0092 ,  A61M5/14 ,  A61M27/00 ,  A61M37/00 ,  A61M2025/1086

Abstract: A reduced pressure delivery system for applying a reduced pressure to a tissue site includes a manifold delivery tube having at least two lumens and a manifold having a plurality of flow channels. The manifold is disposed within a first of the lumens of the manifold delivery tube. A balloon having an inner space and being capable of assuming collapsed and expanded positions is provided. The inner space of the balloon is fluidly connected to a second of the lumens of the manifold delivery tube.

Abstract translation: 用于向组织部位施加减压的减压输送系统包括具有至少两个腔的歧管输送管和具有多个流动通道的歧管。 歧管设置在歧管输送管的第一腔内。 提供了具有内部空间并能够处于折叠和展开位置的气球。 球囊的内部空间流体连接到歧管输送管的第二腔。

公开(公告)号：EP1992308A2

公开(公告)日：2008-11-19

申请号：EP08163004.8

申请日：2000-06-02

Applicant: Microtransform, Inc.

Inventor： Marks, Michael P. ,  Ross, Michael

IPC: A61F2/06 ,  A61B17/12

CPC classification number: A61B17/12113 ,  A61B17/12022 ,  A61B17/12109 ,  A61B17/12136 ,  A61B17/1214 ,  A61B17/12145 ,  A61B17/12163 ,  A61B17/12195 ,  A61B2017/00477 ,  A61B2017/00867 ,  A61B2017/12063 ,  A61B2017/12068 ,  A61B2017/12072 ,  A61B2017/12077 ,  A61B2017/22068 ,  A61B2017/22069 ,  A61M2025/1052

Abstract: An intracorporeal space filling device and a delivery system and method for using the device is disclosed. The space filling device is preferably configured for percutaneous delivery from a peripheral conduit of a patient. The space filling device has all elongated tubular or interconnected bead structure which may have a transmutable material disposed within it. The transmutable material can be altered from a non-rigid state to a rigid state by the application of various types of energy or by other suitable means. The space filling device can be positioned by a delivery system and detached from the delivery system after desired positioning is achieved.

Abstract translation: 公开了一种体内空间填充装置和使用该装置的输送系统和方法。 空间填充装置优选地构造成用于从患者的外围管道经皮输送。 空间填充装置具有全部细长的管状或互连的珠状结构，其中可以具有置于其内的可转换材料。 可转换材料可以通过应用各种类型的能量或通过其他合适的手段从非刚性状态改变为刚性状态。 空间填充装置可以通过输送系统定位并且在达到期望的定位后从输送系统分离。

公开(公告)号：EP1948043A1

公开(公告)日：2008-07-30

申请号：EP06825828.4

申请日：2006-10-13

Applicant: ENDOLUMINAL THERAPEUTICS, INC.

Inventor： SLEPIAN, Marvin, J.

IPC: A61B17/22 ,  A61B17/00 ,  A61B18/24 ,  A61B17/88

CPC classification number: A61B17/3207 ,  A61B17/00491 ,  A61B17/12022 ,  A61B17/12186 ,  A61B17/1219 ,  A61B17/12195 ,  A61B17/22 ,  A61B18/24 ,  A61B2017/00247 ,  A61B2017/1205 ,  A61B2017/22077 ,  A61B2018/00392 ,  A61K35/545

Abstract: Diseases, aging, trauma, environmental exposure, infection and other events or agents can alter tissue function. In one embodiment, treatment is provided by therapeutically altering tissue function. This may be by continuing normal tissue function, suppressing tissue function, or enhancing tissue function. In a preferred embodiment, this treatment is effectuated by penetrating an organ, organ component or tissue structure and placing a supplemental material in a newly created space. This space is generally referred to herein as a "privileged space", i.e. a space not otherwise present in native tissue. Supplemental materials can be deposited and secured within the zone. Supplemental materials include materials forming barriers, supports, and/or materials that deliver agents having a pharmacologic, biochemical, or physiologic effect in vivo. Suitable supplemental materials include polymeric and non-polymeric materials, pharmacologic agents, cells, tissue fragments, microorganisms, viral agents, or other reagents modifying tissue function. The supplemental material is typically in the form of a reservoir/depot, or continuous or discontinuous layer. In one embodiment, supplemental materials, and methods of use thereof, are provided for the continuous or discontinuous therapy of defined regions of an organ, organ component or tissue structure. The supplemental materials may be delivered directly to any one or more of the three zones, endoluminal (or ectomural, for solid organs), endomural, or ectoluminal, of organs, organ components, or tissue structures. The supplemental materials can include natural or synthetic polymeric materials that are biodegradable or non-biodegradable. The supplemental materials can also contain bioactive agents to effectuate a change in an organ or organ component in need thereof. For example, agents that result in a reduced/hyponormal response or an amplified/hypernormal response may be included in the supplemental materials.

公开(公告)号：EP1867300A2

公开(公告)日：2007-12-19

申请号：EP07117926.1

申请日：2000-06-02

Applicant: Sethel Interventional, Inc.

Inventor： Marks, Michael P. ,  Ross, Michael

IPC: A61F2/06 ,  A61B17/12

CPC classification number: A61B17/12113 ,  A61B17/12022 ,  A61B17/12109 ,  A61B17/12136 ,  A61B17/1214 ,  A61B17/12145 ,  A61B17/12163 ,  A61B17/12195 ,  A61B2017/00477 ,  A61B2017/00867 ,  A61B2017/12063 ,  A61B2017/12068 ,  A61B2017/12072 ,  A61B2017/12077 ,  A61B2017/22068 ,  A61B2017/22069 ,  A61M2025/1052

Abstract: An intracorporeal space filling device and a delivery system and method for using the device is disclosed. The space filling device is preferably configured for percutaneous delivery from a peripheral conduit of a patient. The space filling device has an elongated tubular or interconnected bead structure which may have a transmutable material disposed within it. The transmutable material can be altered from a non-rigid state to a rigid state by the application of various types of energy or by other suitable means. The space filling device can be positioned by a delivery system and detached from the delivery system after desired positioning is achieved.

Abstract translation: 公开了体内空间填充装置和使用该装置的输送系统和方法。 空间填充装置优选地构造成用于经皮从患者的外周导管输送。 空间填充装置具有细长的管状或互连的珠粒结构，其可以具有设置在其内的可透过材料。 通过应用各种类型的能量或通过其他合适的方式，可透性材料可以从非刚性状态改变到刚性状态。 空间填充装置可以通过输送系统定位，并且在实现期望的定位之后从输送系统分离。

公开(公告)号：EP1574169A3

公开(公告)日：2007-03-28

申请号：EP05013034.3

申请日：2000-02-01

Applicant: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM

Inventor： Konya, Andras ,  Hyodoh, Hideki ,  Wright, Kenneth C.

IPC: A61B17/12 ,  A61F2/01 ,  A61F2/06

CPC classification number: A61F2/90 ,  A61B17/12118 ,  A61B17/12186 ,  A61B17/12195 ,  A61B2017/00526 ,  A61B2017/00575 ,  A61B2017/00867 ,  A61B2017/12054 ,  A61F2/01 ,  A61F2/856 ,  A61F2/95 ,  A61F2/954 ,  A61F2002/016 ,  A61F2002/018 ,  A61F2002/9511 ,  A61F2210/0004 ,  A61F2220/0016 ,  A61F2220/0075 ,  A61F2230/0006 ,  A61F2230/001 ,  A61F2230/0015 ,  A61F2230/005 ,  A61F2230/0067 ,  A61F2230/0069 ,  A61F2230/0076 ,  A61F2230/0078 ,  A61F2230/008 ,  A61F2230/0091 ,  A61F2230/0093

Abstract: The invention relates to an occluding system, the system comprising a plurality of shape memory wires woven together to form a body useful for occluding an anatomical structure, the body having first and second ends, both ends of at least one shape memory wire being located proximate one end of the body, the shape memory wires crossing each other to form a plurality of angles, at least one of the angles being obtuse; wherein the value of the at least one obtuse angle is increased by axially compressing the body.

公开(公告)号：EP1135068A4

公开(公告)日：2006-07-12

申请号：EP99960236

申请日：1999-11-08

Applicant: EV3 SUNNYVALE INC

Inventor： VAN DER BURG ERIK ,  LESH MICHAEL D ,  DE CICCO DINO ,  FRAZIER ANDREW G C ,  KHAIRKHAHAN ALEX K ,  KREIDLER MARC S ,  ROUE CHAD C

IPC: A61B17/00 ,  A61B17/08 ,  A61B17/11 ,  A61B17/12 ,  A61B17/122

CPC classification number: A61B17/12136 ,  A61B17/0057 ,  A61B17/12022 ,  A61B17/12122 ,  A61B17/12172 ,  A61B17/12186 ,  A61B17/12195 ,  A61B17/122 ,  A61B2017/00243 ,  A61B2017/00575 ,  A61B2017/00579 ,  A61B2017/00592 ,  A61B2017/00597 ,  A61B2017/00606 ,  A61B2017/00615 ,  A61B2017/00632 ,  A61B2017/081 ,  A61B2017/1205

Abstract: This invention is an occlusion device (10) for use in a body lumen such as the left atrial appendage (31). The occlusion device includes an occlusion member (11), and may also include a stabilizing member (12). The stabilizing member inhibits compression of the left atrial appendage, facilitating tissue ingrowth onto the occlusion member. The method of making the device includes forming a plurality of slots in a tube, the slots creating radially outwardly biased longitudinal elements (228). A membrane barrier (15) is then attached to the elements.